138 related articles for article (PubMed ID: 8080687)
1. Suramin inhibits growth and transforming growth factor-beta 1 (TGF-beta 1) binding in osteosarcoma cell lines.
Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
Eur J Cancer; 1994; 30A(5):678-82. PubMed ID: 8080687
[TBL] [Abstract][Full Text] [Related]
2. Expression of transforming growth factor-beta (TGF-beta) receptors, TGF-beta 1 and TGF-beta 2 production and autocrine growth control in osteosarcoma cells.
Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
Int J Cancer; 1994 Aug; 58(3):440-5. PubMed ID: 8050825
[TBL] [Abstract][Full Text] [Related]
3. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
Boylan M; van den Berg HW; Lynch M
Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta-induced mitogenesis of human bone cancer cells.
Datta HK; Zaidi M; Champaneri JB; MacIntyre I
Biochem Biophys Res Commun; 1989 Jun; 161(2):672-6. PubMed ID: 2735916
[TBL] [Abstract][Full Text] [Related]
5. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
6. Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture.
Wade TP; Kasid A; Stein CA; LaRocca RV; Sargent ER; Gomella LG; Myers CE; Linehan WM
J Surg Res; 1992 Aug; 53(2):195-8. PubMed ID: 1405609
[TBL] [Abstract][Full Text] [Related]
7. Effects of TGF beta1 autocrine blockage on osteosarcoma cells.
Liu Y; Zheng QX; Du JY; Yang SH; Shao ZW; Xiao BJ
Chin Med Sci J; 2004 Jun; 19(2):155-6. PubMed ID: 15250258
[TBL] [Abstract][Full Text] [Related]
8. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
[TBL] [Abstract][Full Text] [Related]
10. Suramin suppresses growth, alkaline-phosphatase and telomerase activity of human osteosarcoma cells in vitro.
Trieb K; Blahovec H
Int J Biochem Cell Biol; 2003 Jul; 35(7):1066-70. PubMed ID: 12672477
[TBL] [Abstract][Full Text] [Related]
11. Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells.
Pollak M; Richard M
J Natl Cancer Inst; 1990 Aug; 82(16):1349-52. PubMed ID: 2166171
[TBL] [Abstract][Full Text] [Related]
12. Effects of transforming growth factor beta 1 on the regulation of osteocalcin synthesis in human MG-63 osteosarcoma cells.
Pirskanen A; Jääskeläinen T; Mäenpää PH
J Bone Miner Res; 1994 Oct; 9(10):1635-42. PubMed ID: 7817811
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Weber H; Taylor DS; Molloy CJ
J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of transforming growth factor-beta type I receptor by interferon consensus sequence-binding protein in osteosarcoma cells.
Sung JY; Yoon K; Ye SK; Goh SH; Park SY; Kim JH; Kang HG; Kim YN; Park BK
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):761-772. PubMed ID: 30710564
[TBL] [Abstract][Full Text] [Related]
16. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
Coffey RJ; Leof EB; Shipley GD; Moses HL
J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
[TBL] [Abstract][Full Text] [Related]
17. Suramin inhibits proliferation and DNA synthesis in transitional carcinoma cell lines.
Walther MM; Trahan EE; Cooper M; Venzon D; Linehan WM
J Urol; 1994 Nov; 152(5 Pt 1):1599-602. PubMed ID: 7933214
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factor-beta (TGF beta) isoforms and TGF beta type II receptor messenger ribonucleic acid and protein, and the effect of TGF beta s on endometrial stromal cell growth and protein degradation in vitro.
Tang XM; Zhao Y; Rossi MJ; Abu-Rustum RS; Ksander GA; Chegini N
Endocrinology; 1994 Jul; 135(1):450-9. PubMed ID: 8013384
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution.
Kim JH; Sherwood ER; Sutkowski DM; Lee C; Kozlowski JM
J Urol; 1991 Jul; 146(1):171-6. PubMed ID: 2056586
[TBL] [Abstract][Full Text] [Related]
20. Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer.
Putnam EA; Yen N; Gallick GE; Steck PA; Fang K; Akpakip B; Gazdar AF; Roth JA
Surg Oncol; 1992 Feb; 1(1):49-60. PubMed ID: 1341235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
